127 related articles for article (PubMed ID: 30926432)
21. Phosphorylation of endothelin converting enzyme-1 isoforms: relevance to subcellular localization.
Jafri F; Ergul A
Exp Biol Med (Maywood); 2006 Jun; 231(6):713-7. PubMed ID: 16740986
[TBL] [Abstract][Full Text] [Related]
22. The endothelin axis: a novel target for pharmacotherapy of female malignancies.
Smollich M; Wülfing P
Curr Vasc Pharmacol; 2007 Jul; 5(3):239-48. PubMed ID: 17627567
[TBL] [Abstract][Full Text] [Related]
23. Palmitoylation of the three isoforms of human endothelin-converting enzyme-1.
Schweizer A; Löffler BM; Rohrer J
Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):649-56. PubMed ID: 10359648
[TBL] [Abstract][Full Text] [Related]
24. Endothelin-1 pathway in human alveolar epithelial cell line A549 and human umbilical vein endothelial cells.
Deprez-Roy I; Coge F; Bertry L; Galizzi JP; Feletou M; Vanhoutte PM; Canet E
Acta Pharmacol Sin; 2000 Jun; 21(6):499-506. PubMed ID: 11360683
[TBL] [Abstract][Full Text] [Related]
25. Expression and localization of human endothelin-converting enzyme-1 isoforms in symptomatic atherosclerotic disease and saphenous vein.
Jackson CD; Barnes K; Homer-Vanniasinkam S; Turner AJ
Exp Biol Med (Maywood); 2006 Jun; 231(6):794-801. PubMed ID: 16741001
[TBL] [Abstract][Full Text] [Related]
26. Applicability of green fluorescence protein in the study of endothelin converting enzyme-1c trafficking.
Kuruppu S; Tochon-Danguy N; Smith AI
Protein Sci; 2013 Mar; 22(3):306-13. PubMed ID: 23281075
[TBL] [Abstract][Full Text] [Related]
27. Studies on the expression of endothelin, its receptor subtypes, and converting enzymes in lung cancer and in human bronchial epithelium.
Ahmed SI; Thompson J; Coulson JM; Woll PJ
Am J Respir Cell Mol Biol; 2000 Apr; 22(4):422-31. PubMed ID: 10745023
[TBL] [Abstract][Full Text] [Related]
28. On the role of endothelin-converting enzyme-1 (ECE-1) and neprilysin in human breast cancer.
Smollich M; Götte M; Yip GW; Yong ES; Kersting C; Fischgräbe J; Radke I; Kiesel L; Wülfing P
Breast Cancer Res Treat; 2007 Dec; 106(3):361-9. PubMed ID: 17295044
[TBL] [Abstract][Full Text] [Related]
29. Endothelin-converting enzyme-1 expression in acute and chronic liver injury in fibrogenesis.
Cho TJ; Kim HJ; Cho J
Anim Cells Syst (Seoul); 2019 Jun; 23(3):170-175. PubMed ID: 31231580
[TBL] [Abstract][Full Text] [Related]
30. Hormonal regulation and cell-specific expression of endothelin-converting enzyme 1 isoforms in bovine ovarian endothelial and steroidogenic cells.
Levy N; Gordin M; Smith MF; Bolden-Tiller OU; Meidan R
Biol Reprod; 2003 Apr; 68(4):1361-8. PubMed ID: 12606425
[TBL] [Abstract][Full Text] [Related]
31. Expression of the endothelin-converting enzyme-1 isoforms in endothelial cells.
Muller L; Valdenaire O; Barret A; Korth P; Pinet F; Corvol P; Tougard C
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S15-8. PubMed ID: 11078323
[TBL] [Abstract][Full Text] [Related]
32. Localization of endothelin-converting enzyme in bovine optic nerve and retina.
Dibas A; Prasanna G; Yorio T
J Ocul Pharmacol Ther; 2005 Aug; 21(4):288-97. PubMed ID: 16117692
[TBL] [Abstract][Full Text] [Related]
33. Regulation of the major isoform of human endothelin-converting enzyme-1 by a strong housekeeping promoter modulated by polymorphic microsatellites.
Funke-Kaiser H; Thomas A; Bremer J; Kovacevic SD; Scheuch K; Bolbrinker J; Theis S; Lemmer J; Zimmermann A; Zollmann FS; Herrmann SM; Paul M; Orzechowski HD
J Hypertens; 2003 Nov; 21(11):2111-24. PubMed ID: 14597855
[TBL] [Abstract][Full Text] [Related]
34. A fourth isoform of endothelin-converting enzyme (ECE-1) is generated from an additional promoter molecular cloning and characterization.
Valdenaire O; Lepailleur-Enouf D; Egidy G; Thouard A; Barret A; Vranckx R; Tougard C; Michel JB
Eur J Biochem; 1999 Sep; 264(2):341-9. PubMed ID: 10491078
[TBL] [Abstract][Full Text] [Related]
35. TIMAP-protein phosphatase 1-complex controls endothelin-1 production via ECE-1 dephosphorylation.
Boratkó A; Veréb Z; Petrovski G; Csortos C
Int J Biochem Cell Biol; 2016 Apr; 73():11-18. PubMed ID: 26806547
[TBL] [Abstract][Full Text] [Related]
36. Endothelin-converting enzyme-1 (ECE-1) is a downstream target of the homeobox transcription factor Nkx2-5.
Funke-Kaiser H; Lemmer J; Langsdorff CV; Thomas A; Kovacevic SD; Strasdat M; Behrouzi T; Zollmann FS; Paul M; Orzechowski HD
FASEB J; 2003 Aug; 17(11):1487-9. PubMed ID: 12824294
[TBL] [Abstract][Full Text] [Related]
37. Soluble human endothelin-converting enzyme-1: expression, purification, and demonstration of pronounced pH sensitivity.
Ahn K; Herman SB; Fahnoe DC
Arch Biochem Biophys; 1998 Nov; 359(2):258-68. PubMed ID: 9808768
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological hypothesis: Nitric oxide-induced inhibition of ADAM-17 activity as well as vesicle release can in turn prevent the production of soluble endothelin-converting enzyme.
Kuruppu S; Rajapakse NW; Parkington HC; Smith I
Pharmacol Res Perspect; 2017 Oct; 5(5):. PubMed ID: 28971608
[TBL] [Abstract][Full Text] [Related]
39. Characterization of endothelin-converting enzyme activities in ARPE-19 cells, a human retinal pigmented epithelial cell line.
Dibas A; Prasanna G; Yorio T
J Ocul Pharmacol Ther; 2005 Jun; 21(3):196-204. PubMed ID: 15969636
[TBL] [Abstract][Full Text] [Related]
40. Identification of a novel alternatively spliced variant endothelin converting enzyme-1 lacking a transmembrane domain.
Klipper E; Levy N; Gilboa T; Muller L; Meidan R
Exp Biol Med (Maywood); 2006 Jun; 231(6):723-8. PubMed ID: 16740988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
